CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

COVID-19 PCR and SerologyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug885 Polysomnography Wiki 1.00

Correlated MeSH Terms (4)

Name (Synonyms) Correlation
D020181 Sleep Apnea, Obstructive NIH 1.00
D001049 Apnea NIH 1.00
D012891 Sleep Apnea, NIH 1.00
D011014 Pneumonia NIH 0.07

Correlated HPO Terms (4)

Name (Synonyms) Correlation
HP:0002870 Obstructive sleep apnea HPO 1.00
HP:0002104 Apnea HPO 1.00
HP:0010535 Sleep apnea HPO 1.00
HP:0002090 Pneumonia HPO 0.07

There is one clinical trial.

Clinical Trials

1 Incidence of COVID-19 Test Conversion in Post-surgical Patients

The current Sars-CoV-2 (COVID-19) pandemic has created major changes in how physicians perform routine healthcare for our patients, including elective and non-elective surgical procedures. Beginning on March 16th, 2020 Northwell Health postponed all elective surgeries. As the incidence of COVID-19 cases begins to decrease and hospital volume improves we need to ensure the safety of our patients planning surgical procedures. However, at this time there is a scarcity of data regarding the COVID-19 test conversion rate in surgical patients. Our goal is to determine the COVID-19 test conversion rate in these patients to better guide strategies for restarting surgical care in a large-scale pandemic. Patients will be routinely tested with serology and PCR for COVID-19 24-48 hours prior to their scheduled surgery. Those who provide informed consent will be re-tested 12-16 days after discharge from the hospital to determine any potential nosocomial infection rate. Patients will also answer a few questions during their retest to allow the study team to gauge exposure risk postoperatively after leaving the hospital.

NCT04392323 Sars-CoV2 Diagnostic Test: COVID-19 PCR and Serology

Primary Outcomes

Description: Patients that have negative pre-operative testing that convert to positive testing 14 days post-discharge

Measure: COVID-19 Test Conversion

Time: 14 days

Secondary Outcomes

Description: Days from hospital admission to discharge.

Measure: Duration of Hospitalization

Time: 14 days

Description: Patients will be asked to describe if they have had any exposure to COVID-19 positive persons after their hospital stay.

Measure: Rate of self-reported COVID-19 exposure

Time: 14 days

Description: If patients contract COVID-19 during the postoperative period, what complications occur?

Measure: Rate of complications from COVID-19

Time: 14 days

No related HPO nodes (Using clinical trials)